Table 1.
Characteristics of clinical subjects and healthy controls.
| Clinical characteristics | Controls (n=19) | SSc (n=18) |
|---|---|---|
| Age (Mean ± SD) | 39.8 ± 6.5 | 46.2 ± 12.4 |
| Sex (M/F) | 5/14 | 7/11 |
| Disease duration (months) | NA | 48.7 ± 37.3 |
| Organ involvement | ||
| Interstitial lung disease | NA | 10 |
| PAH | NA | 1 |
| Raynaud's phenomena | NA | 16 |
| Gastrointestinal involvement | NA | 9 |
| Digital ulcer | NA | 5 |
| Serological characteristics | ||
| Anti-Scl-70 | NA | 12 |
| Anti-RNP | NA | 4 |
| Anti-ANA | NA | 16 |
| Anti-dsDNA | NA | 0 |
| Anti-Jo-1 | NA | 0 |
| Anti-Sm | NA | 0 |
| Anti-SSa | NA | 4 |
| Anti-SSb | NA | 0 |
| Anti-ANCA | NA | 1 |
| Medications | ||
| Prednisone | NA | 17 |
| Cyclophosphamide | NA | 7 |